Evaluating inhalation technique among COPD patients comparing 4 different methods

Author(s):  
Anders Løkke ◽  
Karoline Litrup King ◽  
Lotte HK Jørgensen
PLoS ONE ◽  
2018 ◽  
Vol 13 (10) ◽  
pp. e0201188 ◽  
Author(s):  
Wolfram Windisch ◽  
Sarah Bettina Schwarz ◽  
Friederike Sophie Magnet ◽  
Michael Dreher ◽  
Claudia Schmoor ◽  
...  

2021 ◽  
Vol 15 (5) ◽  
pp. 1285-1288
Author(s):  
Askari Mirzaei ◽  
Chitra Bhojan

Objective: Aim of the study was to assess medication adherence to understand various determinants of medication non-adherence in inpatients at a tertiary care hospital, Coimbatore, India. Methodology: It is a prospective observational study conducted in the inpatient department at a Tertiary Care Teaching Hospital. Asthma or COPD patients were randomly recruited over six months from the ward's clinics. The inhalation technique was assed utilizing the questionnaires there were 11 steps for MDI and 12 steps for MDI + spacer each correct technique conveyed a score of 1 and the wrong technic conveyed 0. The adherence to the inhaler technique was assessed utilizing the recipe correct dose/incorrect dose*100 and the purposes behind nonadherence were additionally noted. Result: In our study out of 120 patients 53.3% were diagnosed with COPD and 46.7% were asthmatic, and 10.8% asthmatics and 20% COPD patients were endorsed with budesonide MDI. About 10% of asthmatics and 9.1 COPD patients have endorsed with budesonide MDI+ spacer. About 4.1% asthmatics and 2.5% COPD patients were endorsed with salbutamol MDI. About 17% asthmatics and 10% COPD patients were endorsed with MDI ipratropium and 8% asthmatics and 12.5% COPD patients were recommended with ipratropium MDI+ spacer. At the point when the knowledge concerning the use of inhalers was surveyed utilizing standard questionnaire, which had 11 steps for MDI and 12 steps for MDI+ spacer every questionnaire had scoring of 0 addressing not playing out the progression, 1 addressing following the progression the scores were high after pharmacist intervention when contrasted with before pharmacist intervention Conclusion: The current outcomes feature the requirement for pharmacist interventions pointed toward improving adherence to inhalers in COPD and asthmatic patients. Keywords: adherence, chronic obstructive pulmonary disease, Inhalers, Asthma


2020 ◽  
Vol 2020 ◽  
pp. 1-10
Author(s):  
Wanqing Wang ◽  
Tao Xu ◽  
Qiong Qin ◽  
Liyan Miao ◽  
Jian’an Bao ◽  
...  

Background. Inhalation therapy is the main treatment for asthma and chronic obstructive pulmonary disease (COPD) patients. Owing to the poor inhaler technique in using inhalers, we assessed the effect of a multidimensional pharmaceutical care on inhalation technique in patients with asthma and COPD. Materials and Methods. A 3-month controlled parallel-group study was undertaken in asthma and COPD patients using dry powder inhalers (DPIs). Patients in the intervention group received multidimensional pharmaceutical care, including establishment of a special dispensing window, face-to-face demonstration and education, brochure education, videos education, online consultation and education, and follow-up reeducation. Patients in the control group received usual pharmaceutical care. The inhaler technique score, correctness of inhaler usage, beliefs about medicines questionnaire (BMQ) score, asthma control test (ACT), and COPD assessment test (CAT) were measured pre- and postintervention. Quality of life improvement evaluated according to score changes of ACT in asthma and CAT in COPD and patient satisfaction were measured postintervention. Results. 259 patients finished the study with 133 in the intervention group and 126 in the control group. Compared to preintervention and control group postintervention, the inhaler technique score, correctness of inhaler usage, and ACT score significantly increased in the intervention group postintervention, while the BMQ score and CAT score decreased significantly P < 0.05 . Significant improvements in quality of life and patient satisfaction were found P < 0.05 . Conclusion. This study showed the multidimensional pharmaceutical care for asthma and COPD patients were effective in improving inhalation technique. By providing pharmaceutical care, pharmacists might help asthma and COPD patients to acquire better quality of life.


2020 ◽  
Vol 26 ◽  
Author(s):  
Yingmin Liang ◽  
Judith C.W. Mak

: Asthma and chronic obstructive pulmonary disease (COPD) are obstructive lung diseases which are characterized by chronic inflammation and an increase in mucus production, and are highly prevalent conditions. Despite recent advances and multiple available therapies, there remains a significant unmet medical need. Over the past 40 years, the introduction of new classes of safe and effective therapy is scanty. In spite of the high burden of asthma and COPD among patients, there are fewer new approved therapies in comparison to cardiovascular, metabolic and neurological diseases due to few drug candidates and a higher failure rate in the development of respiratory medicine. Lung diseases are amongst the leading causes of death globally with asthma being one of the most prevalent respiratory diseases, which affects people of all ages but, despite effective therapies available, many patients are poorly controlled and have a low quality of life. COPD is currently ranked the fourth cause of death worldwide and predicted to become the third leading cause of death in 2030. The development of more effective treatments is urgently needed in order to reduce the high mortality rate and the enormous suffering from asthma and COPD. Various inhalation devices with different classes of medications are the foundation as therapies in both asthma and COPD. This article gives a comprehensive review of the promising inhaled therapies in the treatment of asthma and COPD. However, the lack of disease control in asthma and COPD patients may be due to numerous reasons. The association between non-adherence to guidelines on the part of the health care provider and poor inhalation technique and/or non-adherence to the prescribed treatment plan by the patients is common. It is therefore essential to discuss the different delivery systems and the methods used in asthma and COPD patients.


Pneumologia ◽  
2020 ◽  
Vol 69 (2) ◽  
pp. 87-96
Author(s):  
Ruxandra Ulmeanu ◽  
Alina Croitoru ◽  
Floarea Mimi Nitu ◽  
Florin Mihaltan ◽  
Cristian Oancea ◽  
...  

Abstract Background In the management of chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD), adherence to therapy represents a key to success. Objective The objective was to increase adherence to treatment through the development of educational intervention (EI) for asthma and COPD, addressed to patients and general practitioners (GPs). The educational programme includes group educational sessions and educational materials and was carried out in five Romanian hospitals. The results were assessed through Test of Adherence to Inhalers (TAI) questionnaire. Results Of note, 347 GPs and 435 patients were included. Seventy-six per cent of the GPs considered that the main causes of non-adherence are the disease misunderstanding, difficulty of using inhaled medication, fear of adverse effects, the patient’s conviction that no medicine is useful for his illness and financial nature (20%). Fifty-five per cent of surveyed GPs believed that their patients always or most of the time adhere to inhaled therapy but 57% of the same surveyed GPs checked the inhalation technique of their patients sometimes, rarely or never. Only 44% of the GPs discussed with the pulmonologist about their patient’s disease. Before the EI, only 32% of patients had a good adherence score to therapy; this percentage increases to 57% after EI. The most common reasons for non-adherence were: patient forgets to administer his inhalation medication daily (49%), fear of adverse effects (33%), belief that medication is useless (26%), and fear that inhalation medication affects everyday life of the patient (24%). Nearly half of the patients (47%) give up medication when they feel better. Forty per cent of patients drop off inhalation treatments due to financial reasons. The most influenced behaviours as a result of the EI were psychological component (85%), fear of the adverse events (82%) and social component (79%). Conclusions The non-adherence to therapy remains a real problem in asthma and COPD patients in our study group, but EI had positive effects. Extending medical education programmes for patients focused on main reasons of poor adherence, such as forgetting to take medication daily, use of inhalator devices, not understanding their disease, may significantly increase adherence to inhalation treatment.


Sign in / Sign up

Export Citation Format

Share Document